SIGNATURE ESTATE & INVESTMENT ADVISORS LLC
Position in ABCL — AbCellera Biologics Inc.
CIK 1079935
LOS ANGELES, CA
Position in ABCL
as of Mar 31, 2026
· filed Apr 15, 2026
Position Value
$124,481
+$2,497 QoQ
Shares Held
35,668
0.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SIGNATURE ESTATE & INVESTMENT ADVISORS LLC holds $7,978,434 across 6 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
197,419 | $6,986,658 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
1,832 | $448,418 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
478 | $237,436 | |
| 4 | ONC |
BeOne Medicines Ltd.
|
737 | $210,022 | |
| 5 | ENTX |
Entera Bio Ltd.
|
47,328 | $83,770 | |
| 6 | INO |
Inovio Pharmaceuticals, Inc.
|
11,028 | $12,130 |
All Filings in ABCL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $124,481 | 35,668 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $121,984 | 35,668 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $194,500 | 38,668 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $136,061 | 39,668 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $88,459 | 39,668 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $116,227 | 39,668 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $103,136 | 39,668 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $117,417 | 39,668 | Shares | Sole | 2024-07-26 | |
| No filing history on record for this holder in this stock. | ||||||